CTRI Number |
CTRI/2020/08/027214 [Registered on: 18/08/2020] Trial Registered Prospectively |
Last Modified On: |
14/08/2020 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
To study the postoperative pain in patients of lower limb surgeries |
Scientific Title of Study
|
To evaluate the postoperative analgesia of isobaric levobupivacaine alone compared with clonidine or nalbuphine under spinal anesthesia in patients of lower limb surgeries |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Anita Kumari |
Designation |
Professor |
Affiliation |
SGRDIMSAR |
Address |
Department of Anaesthesia,
SGRDIMSAR,
Amritsar Anaesthesia deptt,
Amritsar Amritsar PUNJAB 143501 India |
Phone |
9815632909 |
Fax |
|
Email |
kumarianitadr1@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Sunil Chawla |
Designation |
Professor |
Affiliation |
Sri Guru Ram Das Institute of Medical Sciences and Research |
Address |
Department of Anaesthesia,
SGRDIMSAR,
Amritsar Anaesthesia & Critical carev SGRDIMSAR,
Amritsar Amritsar PUNJAB 143501 India |
Phone |
9915530033 |
Fax |
|
Email |
sgrdanaesthesia.academics@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Balpreet Kaur |
Designation |
Junior Resident |
Affiliation |
SGRDIMSAR |
Address |
SGRDIMSAR,
Amritsar Anaesthesia Deptt,
SGRDIMSAR,
Amritsar Amritsar PUNJAB 143501 India |
Phone |
8283878948 |
Fax |
|
Email |
balpreetkaur55@gmail.com |
|
Source of Monetary or Material Support
|
Sri Guru ram Das Institute of Medical Sciences and Research, Sri Amritsar |
|
Primary Sponsor
|
Name |
NA |
Address |
NA |
Type of Sponsor |
Other [] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Ruchi Gupta |
Sri Guru Ram Das Institute of Medical Sciences & Research |
Operation theatre
Anaesthesia Department
SGRDIMSAR, Amritsar Amritsar PUNJAB |
9814320805
drruchisgrd@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
SGRD ethical committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: M849||Disorder of continuity of bone, unspecified, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Clonidine, nalbuphine with levobupivacaine |
The study will consist of 90 patients randomly divided into three groups of 30 each- group A:0.5% Isobaric levobupivacaine 15mg + 400μg nalbuphine, group B: 0.5% lsobaric levobupivacaine 15mg + 30µg clonidine and group C: only isobaric levobupivacaine 0.5% intrathecally. |
Intervention |
Intrathecal drugs |
groups will be compared with respect to onset and duration of sensory and motor blockade,duration of postoperative analgesia, sedation score, side effects and complications. |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
65.00 Year(s) |
Gender |
Both |
Details |
1.Patients undergoing lower limb surgeries
2. American Society of Anesthesiology (ASA) Grade I and II
|
|
ExclusionCriteria |
Details |
1.Neurological and musculoskeletal disease.
2.Patients with cardiovascular diseases.
3.Contraindications to regional anesthesia such as local infections/sepsis at the site of lumbar puncture, anatomical disorders of spine, shock, any bleeding disorder and patient on anticoagulants.
4.Hypersensitivity to study drugs
5.Pregnant women
6.History of opioid dependence
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Participant and Investigator Blinded |
Primary Outcome
|
Outcome |
TimePoints |
To evaluate the duration of postoperative analgesia of isobaric levobupivacaine alone compared with clonidine or nalbuphine under spinal anesthesia in patients of lower limb surgeries. |
pain will be assessed from 0 min till the 24 hours of the surgery |
|
Secondary Outcome
|
Outcome |
TimePoints |
to evaluate the sedative and adverse effects of all the three drugs in the lower limb surgeries |
effects will be assessed from 0 min till the 24 hours of the surgery |
|
Target Sample Size
|
Total Sample Size="90" Sample Size from India="90"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 3/ Phase 4 |
Date of First Enrollment (India)
|
20/08/2020 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
Nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Hyperbaric bupivacaine 0.5% iscommonly
used in spinal anesthesia. Hyperbaric solutions may cause sudden cardiac arrest
due to hypotension, bradycardia because of higher extend of sympathetic
blockade. The use of isobaric solutions may decrease these risks. Levobupivacaine
is preferred during spinal anesthesia due to its lower cardiovascular
side-effects and central nervous system toxicity. Intrathecal adjuvants are
commonly used to improve the quality of intraoperative analgesia and extend it
in the postoperative period without significant motor or autonomic blockade. |